Conference Preview: Fall Clinical Dermatology Conference 2026

HCPLive is providing on-site coverage of the 2026 Fall Clinical Dermatology Conference, held October 8 to 11 at the Wynn Las Vegas, featuring expert-led therapeutic updates and interviews with dermatology leaders.¹,²

Now in its 46th year, the meeting is chaired by April W. Armstrong, MD, MPH; James Q. Del Rosso, DO; Seemal R. Desai, MD; Gary Goldenberg, MD; Mark Lebwohl, MD; Mark S. Nestor, MD, PhD; Darrell S. Rigel, MD, MS; and Linda F. Stein Gold, MD.² It offers up to 24.25 AMA PRA Category 1 Credits™ through the joint providership of the University of Nevada, Reno School of Medicine and CMEsquared.²

Over the course of this 4-day meeting, dermatologists, researchers, and other skin health professionals will convene to review new data, practical treatment strategies, and evolving approaches across medical, surgical, and aesthetic dermatology.

What to Expect at Fall Clinical 2026 in Las Vegas:

This year’s program features symposia, focused seminars, and rapid-fire DermDash sessions. Topics span atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, alopecia areata, chronic spontaneous urticaria, skin cancer, and the growing role of artificial intelligence (AI) in dermatology practice.²

HCPLive will be on-site throughout the conference, providing exclusive interviews with dermatology leaders, coverage of notable sessions, and reporting on the latest clinical insights shared during the meeting.

Key Interviews at Fall Clinical:

• Tina Bhutani-Jacques, MD, MAS
• David Cotter, MD, PhD
• Shannon C. Trotter, DO, FAOCD
• Iltefat Hamzavi, MD
• Art Papier, MD
• Raj Chovatiya, MD, PhD
• Eingun James Song, MD

Seminars-In-Depth to Watch:

JAK inhibitors in vitiligo: Hamzavi and Abrar A. Qureshi, MD, MPH, examine the evolving role of Janus kinase (JAK) inhibition in vitiligo (Thursday, October 8)

Nonsteroidal topicals in atopic dermatitis: Brad P. Glick, DO, MPH, and Stein Gold discuss individualizing topical therapy as nonsteroidal options expand (Thursday, October 8)

IL-17 inhibitors in psoriatic disease: Glick and Lebwohl share head-to-head insights on interleukin (IL)-17 inhibitors (Friday, October 9)

Chronic spontaneous urticaria: Shawn Kwatra, MD, and Michelle Tarbox, MD, present case-based management in the era of targeted therapies (Saturday, October 10).

Cutaneous squamous cell carcinoma: Trotter and Todd E. Schlesinger, MD, offer a deep dive on the disease and the latest in immunotherapy (Saturday, October 10)

DermDash Sessions to Watch:

Acne: Christopher G. Bunick, MD, PhD, presents case-based approaches for daily practice (Thursday, October 8)

Chronic spontaneous urticaria: Naiem T. Issa, MD, PhD, reviews KIT-targeted approaches (Thursday, October 8)

Sunscreen: Henry W. Lim, MD, and Rigel ask whether bemotrizinol changes which sunscreen clinicians recommend (Friday, October 9)

Sessions to Watch:

Among the many sessions on this year’s agenda, the following offer practical updates for clinicians attending the conference.

What Have We Learned About Skin of Color? What Can We Use To Improve Outcomes?

Thursday, October 8 • 9:35–9:50 AM PDT • Bandol

Overview: Andrew F. Alexis, MD, MPH, and Tiffany Mayo, MD, MSc, will review lessons learned in skin of color dermatology and the tools clinicians can use to improve outcomes for patients with skin of color.

When to Start, When to Switch: Positioning JAK Inhibitors in Atopic Dermatitis Management

Thursday, October 8 • 9:50–10:35 AM PDT • Bandol

Overview: This satellite symposium will address evidence-based use of JAK inhibitors in atopic dermatitis following inadequate response, as well as how to counsel patients about safety and treatment expectations. Faculty include Bunick, Diego Ruiz Dasilva, MD, and Ruth Ann Vleugels, MD, MPH, MBA.

The Next Chapter in Psoriasis Therapy: The Role of New and Emerging TYK2 Inhibitors

Thursday, October 8 • 2:05–2:50 PM PDT • Bandol

Overview: Speakers will discuss how to incorporate treat-to-target benchmarks into psoriasis treatment plans. They will also cover how selective tyrosine kinase 2 (TYK2) inhibition differs from broader JAK inhibition, and where new and emerging TYK2 inhibitors may fit in optimizing disease control. Faculty include Edward (Ted) Lain, MD, MBA; Stein Gold; and Ronald Vender, MD.

Oral Psoriasis Therapies: A Brighter Horizon

Friday, October 9 • 10:25–11:10 AM PDT • Cristal 2, 4, & 6

Overview: Armstrong, Tina Bhutani, MD, and Song will explore the potential of oral therapies to fill unmet needs in psoriasis care. They will also provide clinical updates on emerging and approved oral agents and discuss incorporating these agents into patient-centered treatment planning.

Better Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis: An Interactive Expert Exchange

Friday, October 9 • 11:30 AM–12:15 PM PDT • Cristal 2, 4, & 6

Overview: Armstrong, Chovatiya, and Elizabeth (Lisa) A. Swanson, MD, will discuss when to escalate therapy and how to differentiate biologics for individualized treatment selection. They will also share strategies for strengthening patient and caregiver communication to support lasting adherence and disease control.

Bridging Perspectives: A Multispecialty Roundtable on GLP-1 Receptor Agonists in Psoriasis

Saturday, October 10 • 2:15–3:15 PM PDT • Bandol 2

Overview: Chaired by Joel M. Gelfand, MD, MSCE, FAAD, this CME workshop will explore how glucagon-like peptide-1 (GLP-1) receptor agonists affect the intersection of obesity and psoriasis. Five interactive stations, each led by a different specialist or patient advocate, will share real-world clinical pearls for common provider and patient challenges.

The HCPLive team will provide ongoing coverage from Las Vegas, including session highlights, expert interviews, and key clinical takeaways from the 2026 Fall Clinical Dermatology Conference.

Editor’s note: This summary was created with the help of AI tools.

References

1. CMEsquared. Fall Clinical Dermatology Conference 2026. Accessed October 8, 2026. https://web.cvent.com/event/cc8afeea-ca2c-46e7-af52-a227f8af567d.

2. CMEsquared. 2026 Fall Clinical Dermatology Conference in-person agenda. Updated September 30, 2026. Accessed October 8, 2026.